Scholars Central

ArticlePublished 28 Apr 2014

Cefpodoxime Proxetil: Consumer Friendly Palatable Formulations

Authors: Naikkhanvte NS, Kapuriya N, Rajarajeshwari N

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Cefpodoxime proxetil, a third generation antibiotic used to treat upper and lower respiratory tract infections is bitter in taste thereby hampering the development of a palatable oral dosage form. In this study, Cefpodoxime proxetil was taste masked by microencapsulation technique (solvent evaporation method) with methacrylic acid copolymer (EcopolTM) in various ratios of drug and polymer. The taste masked microspheres were incorporated into dispersible tablets and dry syrup for reconstitution. Tablets were prepared by direct compression technique. Dry syrup was prepared using sweeteners, flavors and diluents. The formulations were evaluated for quality control parameters. Results indicated successful formulation of mouth dissolving tablets and dry syrup for reconstitution with optimum physicochemical properties.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Asian Journal of Biomedical and Pharmaceutical Sciences.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalAsian Journal of Biomedical and Pharmaceutical Sciences
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Naikkhanvte NS”
  • BylineArticles whose byline prints “Kapuriya N”
  • BylineArticles whose byline prints “Rajarajeshwari N”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels